PancreasFest 2025: Pancreas Disease Across the Lifespan
- Institution
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA
- Principal investigator
- Randall Brand
- Funding
- $24K
- Duration
- 2025–2026
Moonbase score
Still being scored
Abstract
Advancing our understanding of human pancreatic diseases, especially pancreatitis and pancreatic cancer, requires the cooperative effort of a network of clinical centers of excellence and the regular meeting of thought leaders in the field. The course objectives for PancreasFest 2025 will enhance progress on meeting research priorities highlighted by the NIH and NIDDK. Specifically, we will 1) Critically review genetic and environmental risk factors associated with development of pancreatic diseases; 2) Critically review pancreatic cancer early diagnosis and treatment modalities; and 3) Discuss strategies for translation of new scientific discoveries into clinical trials and practice, including needs analysis. The University of Pittsburgh managed the PancreasFest conference from 2004 to 2022 and give the meeting its full support since course manager was transferred to the Collaborative Alliance for Pancreatic Education and Research (CAPER) in 2022. CAPER is our solid partner and is a nonprofit devoted to enhancing the career development of junior physician scientists in the field of pancreatology. No other conference in the U.S. focuses exclusively on fostering translational multi-center programs for pancreatic disorders. Attendees of past meetings uniformly praise PancreasFest for fostering collaborative research and for its emphasis on the importance of a small conference focused on pancreatic disorders. Multiple clinical working groups have emerged over the years through PancreasFest which focus on areas of NIDDK interest. 250+ physicians, scientists, and medical professionals from varied medical disciplines attend PancreasFest each year, including: pancreatologists, endoscopists, surgeons, radiologists, pathologists, molecular biologists, pediatricians, geneticists, epidemiologists, statisticians, systems biologists, subspecialty medical professionals, and experts in biomarkers. We encourage attendance from junior faculty, fellows, and trainees to ensure that the next generation of pancreatic investigators works directly with and learns from senior researchers in the field and is aware of the breadth of treatment challenges. Key staff from the NIDDK are invited to provide perspective and to discuss key priorities. PancreasFest is also attended by representatives from industry and patient-focused foundations, such as CAPER, Mission:Cure, and the National Pancreas Foundation. PancreasFest 2025 will be held at the University of Pittsburgh William Pitt Student Union in the Oakland section of Pittsburgh, PA on July 24 & 25, 2025. NIDDK-sponsored sessions will be part of PF25, which include meetings from the International Study Group of Pediatric Pancreatitis In Search of a Cure (INSPPIRE) and the annual meeting of CAPER. .
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF PITTSBURGH AT PITTSBURGH
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of Pittsburgh at PittsburghNot yet scored
Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma
Surinder K. Batra · $1.3M · 2016–2028
- NIH · University of Pittsburgh at Pittsburgh64
Core E: Omics Core
Sid E O'Bryant · $3.2M · 2020–2026
- NIH · University of Pittsburgh at Pittsburgh60
Project 3: Biomarkers for DS Clinical Trials
Sid E O'Bryant · $148K · 2020–2026